Chemomab Therapeutics Ltd (CMMB)
0.5881
-0.07
(-10.99%)
USD |
NASDAQ |
Apr 17, 16:00
0.5881
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics Cash from Operations (TTM): -25.63M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
June 30, 2023 | -25.63M |
March 31, 2023 | -23.84M |
December 31, 2022 | -20.37M |
September 30, 2022 | -17.56M |
June 30, 2022 | -14.89M |
March 31, 2022 | -14.79M |
Date | Value |
---|---|
December 31, 2021 | -12.37M |
September 30, 2021 | -11.04M |
June 30, 2021 | -9.356M |
March 31, 2021 | -4.622M |
December 31, 2020 | -5.242M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-25.63M
Minimum
Jun 2023
-4.622M
Maximum
Mar 2021
-14.52M
Average
-14.79M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
Compugen Ltd | -- |
Pluri Inc | -18.47M |
BioLine Rx Ltd | -22.61M |
Can Fite Biofarma Ltd | -- |
BiomX Inc | -21.29M |